查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1404711

静脉注射液市场规模、份额、趋势分析报告：按产品、按营养素、按地区、细分市场预测，2024-2030 年

Intravenous Solutions Market Size, Share & Trends Analysis Report By Product (TPN, PPN), By Nutrients (Carbohydrates, Vitamins & Minerals, Single-dose Amino Acids) By Region (Asia Pacific, North America), And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 114 Pages | 商品交期: 2-10个工作天内

价格

静脉注射解决方案市场成长与趋势：

Grand View Research, Inc.最新报告显示，到2030年，全球静脉注射解决方案市场规模预计将达到220亿美元，预测期内复合年增长率为8%。

早产在印度和中国等新兴国家尤其普遍，预计将在预测期内推动市场成长。据世界卫生组织称，十分之一的婴儿早产，这是全世界关注的问题。因此，新兴国家早产发生率较高、医疗基础设施改善、医疗成本上升和患者意识预计将在预测期内作为市场驱动因素产生重大影响。

肠外脂肪乳化的使用是基于各权威机构对降低早产死亡率的广泛关注。截至2021年，美国的早产率约为10.5%。此外，每年因早产造成的社会和经济成本估计为 252 亿美元。因此，大量生产后需要补充营养的新生儿预计将在预测期内推动市场需求。

此外，还有几项研究证明对患有营养不良问题的患者使用肠外营养是合理的，这些问题在大流行期间有所增加，从而导致市场成长。例如，发表在《营养与饮食学会杂誌》上的一篇论文发现，许多入住 ICU 接受 COVID-19 治疗的患者患有急性营养不良。因此，预计疫情期间肠外营养产品的市场使用量将会增加。

据报道，某些微量营养素和维生素的缺乏在 COVID-19 阳性患者中很常见且有害。因此，建议这些患者静脉注射以满足建议的用餐摄取量。对于 COVID-19 患者，医生和营养专家更喜欢肠外营养而不是经肠营养。这是因为经肠营养特别需要放置鼻胃管，这会干扰为 COVID-19 患者提供的非侵入性通气。由于误吸营养液和营养不良的风险增加，住院的 COVID-19 患者越来越多地采用肠外营养。

静脉注射解决方案市场报告亮点

  • 到 2023 年，全肠外营养 (TPN) 领域预计将占据 66.3% 的主导市场占有率，并在预测期内呈现最高成长率（复合年增长率为 8.2%）。 TPN 涉及透过静脉注射 (IV) 技术给药一套全面的营养物质。
  • 2023年，单给药胺基酸溶液领域将引领市场，占31.6%的主要份额。研究表明，单给药氨基酸提供了完整的蛋白质来源，可以轻鬆地与其他肠胃外製剂一起定制，并且易于给药。
  • Assure Infusions, Inc. 宣布投资 2,000 万美元在佛罗里达州巴托建设先进的製造工厂，以解决美国输液液的供需缺口。

目录

第一章调查方法和范围

第 2 章执行摘要

第三章静脉溶液市场变数和趋势

  • 静脉注射解决方案市场的系统展望
    • 附随市场前景
  • 市场动态
    • 市场驱动因素影响分析
    • 市场抑制因素分析
  • 法律规范
    • 标准和合规性
    • 赎回场景
  • COVID-19 大流行的影响
  • 产业分析工具
    • 波特的分析
    • 宏观经济分析

第四章静脉注射解决方案市场：产品分析

  • 2023年及2030年产品变化分析及市场占有率
  • 副产品
  • 全肠外营养
    • 完整肠外营养市场，2018-2030
  • 週边肠外营养
    • 週边肠外营养市场，2018-2030

第五章静脉注射液市场：营养分析

  • 2023年及2030年营养成分变化分析及市场占有率
  • 按营养成分
  • 碳水化合物
    • 碳水化合物市场，2018-2030
  • 单剂量氨基酸给药
    • 单剂量氨基酸给药市场，2018-2030
  • 维生素和矿物质
    • 维生素和矿物质，2018-2030
  • 肠外脂肪乳化
    • 肠外脂肪乳化，2018-2030
  • 其他的
    • 其他市场，2018-2030

第六章 静脉注射液市场：区域估计与趋势分析

  • 静脉注射解决方案市场：区域展望
  • 北美洲
    • 2018-2030 年北美静脉注射液市场估计与预测
    • 美国
    • 加拿大
  • 欧洲
    • 2018-2030 年欧洲静脉注射溶液市场估计与预测
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 2018-2030 年亚太地区静脉注射解决方案市场估计与预测
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 2018-2030 年拉丁美洲静脉注射溶液市场估计与预测
    • 墨西哥
    • 巴西
    • 阿根廷
  • 中东和非洲 (MEA)
    • 2018-2030 年中东和非洲静脉注射溶液市场估计和预测
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第七章竞争分析

  • 公司分类
    • Fresenius Kabi AG
    • Pfizer Inc.
    • Otsuka Pharmaceutical Co. Ltd.
    • Baxter, B. Braun Melsungen AG
    • Vifor Pharma Management Ltd.
    • JW Life Science
  • Participants'Overview
  • 财务绩效
  • 产品基准评效
  • 市场参与企业分类
    • 热图分析
  • 2022 年公司市场占有率分析
  • 策略规划
    • 併购
    • 产品发表会
    • 伙伴关係与协作
    • 产品核准
    • 扩张
    • 其他的

第8章分析师的观点

Product Code: GVR-1-68038-137-5

Intravenous Solutions Market Growth & Trends:

The global intravenous solutions market size is expected to reach USD 22.0 billion by 2030, registering a CAGR of 8% during the forecast period, according to a new report by Grand View Research, Inc. The high prevalence of preterm births, especially in emerging economies such as India and China, is expected to drive market growth during the forecast period. According to WHO, 1 in 10 babies are born preterm, and this is a global concern. Thus, the high incidence of preterm births in emerging economies, improved healthcare infrastructure, and growing healthcare expenditure & patient awareness are expected to be high impact rendering drivers of the market during the forecast period.

The use of parenteral lipid emulsions is driven by the extensive focus of various authorities to limit preterm birth mortality. As of 2021, the preterm birth rate in the U.S. was about 10.5%. Moreover, the annual societal, and economic cost was estimated at USD 25.2 billion for preterm births. Hence, the presence of many neonates requiring supplementary postbirth nutrition is expected to boost the market demand over the forecast period.

In addition, several studies justify the use of parenteral nutrition for patients suffering from malnutrition problems, which increased during the pandemic, leading to market growth. For instance, according to an article published in the Journal of the Academy of Nutrition and Dietetics, many patients admitted to the ICU for COVID-19 treatment suffer from acute malnourishment. Hence, the usage of parenteral nutrition products is expected to increase in the market during the pandemic.

In COVID-19-positive patients, high deficiency of specific micronutrients and vitamins has been reported to be detrimental. Thus, intravenous administration is recommended in such patients to meet the recommended dietary intake. Physicians and nutrition specialists preferred parenteral nutrition over enteral nutrition in COVID-19 patients since enteral nutrition specifically requires the setup of nasogastric tubes, which hampers the noninvasive ventilation provided to COVID-19 patients. The increased risk of nutritional solution aspiration and underfeeding in hospitalized patients for COVID-19 has led to increased adoption of parenteral nutrition.

Intravenous Solutions Market Report Highlights:

  • In 2023, the Total Parenteral Nutrition (TPN) segment held a dominant market share of 66.3% and is projected to experience the highest growth rate (CAGR of 8.2%) during the forecast period. TPN involves administering a comprehensive set of nutrients through an intravenous (IV) technique
  • In 2023, the market was led by the single-dose amino acid solution segment, holding a significant share of 31.6%. Studies have shown that single-dose amino acids offer a complete protein source, are easily customizable with other parenteral formulations, and are straightforward to administer
  • In 2023, North America held a dominant market share of 41%, credited to key players, favorable regulations, and strong reimbursement in countries like the U.S. Assure Infusions, Inc. announced a USD 20 million investment to build an advanced manufacturing facility in Bartow, Florida, addressing the IV solutions demand-supply gap in the U.S.

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market Segmentation
    • 1.1.1 Segment Definitions
      • 1.1.1.1 Product Segment
      • 1.1.1.2 Nutrient Segment
  • 1.2 Regional Scope
  • 1.3 Estimates And Forecast Timeline
  • 1.4 Objectives
    • 1.4.1 Objective - 1
    • 1.4.2 Objective - 2
    • 1.4.3 Objective - 3
  • 1.5 Research Methodology
  • 1.6 Information Procurement
    • 1.6.1 Purchased Database
    • 1.6.2 GVR's Internal Database
    • 1.6.3 Secondary Sources
    • 1.6.4 Primary Research
  • 1.7 Information Or Data Analysis
    • 1.7.1 Data Analysis Models
  • 1.8 Market Formulation & Validation
  • 1.9 Model Details
    • 1.9.1 Commodity Flow Analysis
      • 1.9.1.1 Research Scope And Assumptions
  • 1.10 List Of Secondary Sources
  • 1.11 List Of Primary Sources
  • 1.12 List Of Abbreviations

Chapter 2 Executive Summary

  • 2.1 Market Snapshot
  • 2.2 Segment Snapshot
  • 2.3 Competitive Landscape

Chapter 3 Intravenous Solutions Market Variables And Trends

  • 3.1 Intravenous Solutions Market Lineage Outlook
    • 3.1.1 Ancillary Market Outlook
  • 3.2 Market Dynamics
    • 3.2.1 Market Driver Impact Analysis
      • 3.2.1.1 Growing Number Of Premature Births
      • 3.2.1.2 Increasing Incidence Of Cancer
      • 3.2.1.3 Increasing Risk Of Malnutrition
      • 3.2.1.4 Growing Geriatric Population
    • 3.2.2 Market Restraint Analysis
      • 3.2.2.1 Shortage Of Parenteral Nutrition Products
      • 3.2.2.2 Increased Use Of Enteral Nutrition
      • 3.2.2.3 High Risk Of Infections
  • 3.3 Regulatory Framework
    • 3.3.1 Standards And Compliances
      • 3.3.1.1 North America
      • 3.3.1.2 Europe
      • 3.3.1.3 Apac
      • 3.3.1.4 Latin America
      • 3.3.1.5 Mea
    • 3.3.2 Reimbursement Scenario
      • 3.3.2.1 U.S.
      • 3.3.2.2 Canada
      • 3.3.2.3 Germany
      • 3.3.2.4 UK
      • 3.3.2.5 Japan
      • 3.3.2.6 Australia
      • 3.3.2.7 China
  • 3.4 Impact Of Covid-19 Pandemic
  • 3.5 Industry Analysis Tools
    • 3.5.1 Porter's Analysis
    • 3.5.2 Macroeconomic Analysis

Chapter 4 Intravenous Solutions Market: Product Analysis

  • 4.1 Product Movement Analysis & Market Share, 2023 & 2030
  • 4.2 Intravenous Solutions Market Estimates & Forecast, By Product (Revenue In USD Million And Volume In Thousand Units)
  • 4.3 Total Parenteral Nutrition
    • 4.3.1 Total Parenteral Nutrition Market, 2018 - 2030 (Revenue In USD Million And Volume In Thousand Units)
  • 4.4 Peripheral Parenteral Nutrition
    • 4.4.1 Peripheral Parenteral Nutrition Market, 2018 - 2030 (Revenue In USD Million And Volume In Thousand Units)

Chapter 5 Intravenous Solutions Market: Nutrients Analysis

  • 5.1 Nutrients Movement Analysis & Market Share, 2023 & 2030
  • 5.2 Intravenous Solutions Market Estimates & Forecast, By Nutrients (Revenue In USD Million And Volume In Thousand Units)
  • 5.3 Carbohydrates
    • 5.3.1 Carbohydrates Market, 2018 - 2030 (Revenue In USD Million And Volume In Thousand Units)
  • 5.4 Single-dose Amino Acid Solution
    • 5.4.1 Single-dose Amino Acid Solution Market, 2018 - 2030 (Revenue In USD Million And Volume In Thousand Units)
  • 5.5 Vitamins & Minerals
    • 5.5.1 Vitamins & Minerals, 2018 - 2030 (Revenue In USD Million And Volume In Thousand Units)
  • 5.6 Parenteral Lipid Emulsion
    • 5.6.1 Parenteral Lipid Emulsion, 2018 - 2030 (Revenue In USD Million And Volume In Thousand Units)
  • 5.7 Others
    • 5.7.1 Others Market, 2018 - 2030 (Revenue In USD Million And Volume In Thousand Units)

Chapter 6 Intravenous Solutions Market: Regional Estimates & Trend Analysis

  • 6.1 Intravenous Solutions Market: Regional Outlook
  • 6.2 North America
    • 6.2.1 North America Intravenous Solutions Market Estimates And Forecasts, 2018 - 2030 (Revenue In USD Million And Volume In Thousand Units)
    • 6.2.2 U.S.
      • 6.2.2.1 Key Country Dynamics
      • 6.2.2.2 U.S. Intravenous Solutions Market Estimates And Forecasts, 2018 - 2030 (Revenue In USD Million And Volume In Thousand Units)
    • 6.2.3 Canada
      • 6.2.3.1 Key Country Dynamics
      • 6.2.3.2 Canada Intravenous Solutions Market Estimates And Forecasts, 2018 - 2030 (Revenue In USD Million And Volume In Thousand Units)
  • 6.3 Europe
    • 6.3.1 Europe Intravenous Solutions Market Estimates And Forecasts, 2018 - 2030 (Revenue In USD Million And Volume In Thousand Units)
    • 6.3.2 UK
      • 6.3.2.1 Key Country Dynamics
      • 6.3.2.2 UK Intravenous Solutions Market Estimates And Forecasts, 2018 - 2030 (Revenue In USD Million And Volume In Thousand Units)
    • 6.3.3 Germany
      • 6.3.3.1 Key Country Dynamics
      • 6.3.3.2 Germany Intravenous Solutions Market Estimates And Forecasts, 2018 - 2030 (Revenue In USD Million And Volume In Thousand Units)
    • 6.3.4 France
      • 6.3.4.1 Key Country Dynamics
      • 6.3.4.2 France Intravenous Solutions Market Estimates And Forecasts, 2018 - 2030 (Revenue In USD Million And Volume In Thousand Units)
    • 6.3.5 Italy
      • 6.3.5.1 Key Country Dynamics
      • 6.3.5.2 Italy Intravenous Solutions Market Estimates And Forecasts, 2018 - 2030 (Revenue In USD Million And Volume In Thousand Units)
    • 6.3.6 Spain
      • 6.3.6.1 Key Country Dynamics
      • 6.3.6.2 Spain Intravenous Solutions Market Estimates And Forecasts, 2018 - 2030 (Revenue In USD Million And Volume In Thousand Units)
    • 6.3.7 Denmark
      • 6.3.7.1 Key Country Dynamics
      • 6.3.7.2 Denmark Intravenous Solutions Market Estimates And Forecasts, 2018 - 2030 (Revenue In USD Million And Volume In Thousand Units)
    • 6.3.8 Sweden
      • 6.3.8.1 Key Country Dynamics
      • 6.3.8.2 Sweden Intravenous Solutions Market Estimates And Forecasts, 2018 - 2030 (Revenue In USD Million And Volume In Thousand Units)
    • 6.3.9 Norway
      • 6.3.9.1 Key Country Dynamics
      • 6.3.9.2 Norway Intravenous Solutions Market Estimates And Forecasts, 2018 - 2030 (Revenue In USD Million And Volume In Thousand Units)
  • 6.4 Asia Pacific
    • 6.4.1 Asia Pacific Intravenous Solutions Market Estimates And Forecasts, 2018 - 2030 (Revenue In USD Million And Volume In Thousand Units)
    • 6.4.2 Japan
      • 6.4.2.1 Key Country Dynamics
      • 6.4.2.2 Japan Intravenous Solutions Market Estimates And Forecasts, 2018 - 2030 (Revenue In USD Million And Volume In Thousand Units)
    • 6.4.3 China
      • 6.4.3.1 Key Country Dynamics
      • 6.4.3.2 China Intravenous Solutions Market Estimates And Forecasts, 2018 - 2030 (Revenue In USD Million And Volume In Thousand Units)
    • 6.4.4 India
      • 6.4.4.1 Key Country Dynamics
      • 6.4.4.2 India Intravenous Solutions Market Estimates And Forecasts, 2018 - 2030 (Revenue In USD Million And Volume In Thousand Units)
    • 6.4.5 Australia
      • 6.4.5.1 Key Country Dynamics
      • 6.4.5.2 Australia Intravenous Solutions Market Estimates And Forecasts, 2018 - 2030 (Revenue In USD Million And Volume In Thousand Units)
    • 6.4.6 South Korea
      • 6.4.6.1 Key Country Dynamics
      • 6.4.6.2 South Korea Intravenous Solutions Market Estimates And Forecasts, 2018 - 2030 (Revenue In USD Million And Volume In Thousand Units)
    • 6.4.7 Thailand
      • 6.4.7.1 Key Country Dynamics
      • 6.4.7.2 Thailand Intravenous Solutions Market Estimates And Forecasts, 2018 - 2030 (Revenue In USD Million And Volume In Thousand Units)
  • 6.5 Latin America
    • 6.5.1 Latin America Intravenous Solutions Market Estimates And Forecasts, 2018 - 2030 (Revenue In USD Million And Volume In Thousand Units)
    • 6.5.2 Mexico
      • 6.5.2.1 Key Country Dynamics
      • 6.5.2.2 Mexico Intravenous Solutions Market Estimates And Forecasts, 2018 - 2030 (Revenue In USD Million And Volume In Thousand Units)
    • 6.5.3 Brazil
      • 6.5.3.1 Key Country Dynamics
      • 6.5.3.2 Brazil Intravenous Solutions Market Estimates And Forecasts, 2018 - 2030 (Revenue In USD Million And Volume In Thousand Units)
    • 6.5.4 Argentina
      • 6.5.4.1 Key Country Dynamics
      • 6.5.4.2 Argentina Intravenous Solutions Market Estimates And Forecasts, 2018 - 2030 (Revenue In USD Million And Volume In Thousand Units)
  • 6.6 Middle East & Africa (Mea)
    • 6.6.1 Mea Intravenous Solutions Market Estimates And Forecasts, 2018 - 2030 (Revenue In USD Million And Volume In Thousand Units)
    • 6.6.3 South Africa
      • 6.6.3.1 Key Country Dynamics
      • 6.6.3.2 South Africa Intravenous Solutions Market Estimates And Forecasts, 2018 - 2030 (Revenue In USD Million And Volume In Thousand Units)
    • 6.6.4 Saudi Arabia
      • 6.6.4.1 Key Country Dynamics
      • 6.6.4.2 Saudi Arabia Intravenous Solutions Market Estimates And Forecasts, 2018 - 2030 (Revenue In USD Million And Volume In Thousand Units)
    • 6.6.5 UAE
      • 6.6.5.1 Key Country Dynamics
      • 6.6.5.2 UAE Intravenous Solutions Market Estimates And Forecasts, 2018 - 2030 (Revenue In USD Million And Volume In Thousand Units)
    • 6.6.6 Kuwait
      • 6.6.6.1 Key Country Dynamics
      • 6.6.6.2 Kuwait Intravenous Solutions Market Estimates And Forecasts, 2018 - 2030 (Revenue In USD Million And Volume In Thousand Units)

Chapter 7 Competitive Analysis

  • 7.1 Company Categorization
    • 7.1.1 Fresenius Kabi AG
    • 7.1.2 Pfizer Inc.
    • 7.1.3 Otsuka Pharmaceutical Co. Ltd.
    • 7.1.4 Baxter, B. Braun Melsungen AG
    • 7.1.5 Vifor Pharma Management Ltd.
    • 7.1.6 JW Life Science
  • 7.2 Participants' Overview
  • 7.3 Financial Performance
  • 7.4 Product Benchmarking
  • 7.5 Market Participant Categorization
    • 7.5.1 Heat Map Analysis
  • 7.6 Company Market Share Analysis, 2022
  • 7.7 Strategy Mapping
    • 7.7.1 Mergers & Acquisitions
    • 7.7.2 Product Launch
    • 7.7.3 Partnerships & Collaborations
    • 7.7.4 Product Approvals
    • 7.7.5 Expansion
    • 7.7.6 Others

Chapter 8 Analyst Perspective

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations

List of Figures

  • Fig. 1 Intravenous solutions market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value chain based sizing & forecasting
  • Fig. 7 QFD modelling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 Market snapshot
  • Fig. 10 Segment snapshot
  • Fig. 11 Competitive landscape
  • Fig. 12 Intravenous solutions market dynamics
  • Fig. 13 Preterm birth rates in the U.S., 2011 to 2030
  • Fig. 14 Number of undernourished people in the world, 2015 - 2020 (Million and Percentage)
  • Fig. 15 Intravenous solutions market: PORTER's analysis
  • Fig. 16 Intravenous solutions market: PESTEL analysis
  • Fig. 17 Intravenous solutions market: by product: key takeaways
  • Fig. 18 Intravenous solutions market, by product: market share, 2023 & 2030
  • Fig. 19 Total parenteral nutrition market, 2018 - 2030 (USD Million)
  • Fig. 20 Peripheral parenteral nutrition market, 2018 - 2030 (USD Million)
  • Fig. 21 Intravenous solutions market, by end-use: key takeaways
  • Fig. 22 Intravenous solutions market, by nutrients: market share, 2023 & 2030
  • Fig. 23 Carbohydrates market, 2018 - 2030 (USD Million)
  • Fig. 24 Single dose amino acid solution market, 2018 - 2030 (USD Million)
  • Fig. 25 Vitamins and minerals, 2018 - 2030 (USD Million)
  • Fig. 26 Parenteral lipid emulsion, 2018 - 2030 (USD Million)
  • Fig. 27 Others market, 2018 - 2030 (USD Million)
  • Fig. 28 Intravenous solutions market revenue, by region, 2023 & 2030 (USD Million)
  • Fig. 29 Regional marketplace: key takeaways
  • Fig. 30 Regional marketplace: key takeaways
  • Fig. 31 North America intravenous solutions market, 2018 - 2030 (USD Million)
  • Fig. 32 Key country dynamics
  • Fig. 33 U.S. intravenous solutions market, 2018 - 2030 (USD Million)
  • Fig. 34 Key country dynamics
  • Fig. 35 Canada intravenous solutions market, 2018 - 2030 (USD Million)
  • Fig. 36 Europe intravenous solutions market, 2018 - 2030 (USD Million)
  • Fig. 37 Key country dynamics
  • Fig. 38 UK intravenous solutions market, 2018 - 2030 (USD Million)
  • Fig. 39 Key country dynamics
  • Fig. 40 Germany intravenous solutions market, 2018 - 2030 (USD Million)
  • Fig. 41 Key country dynamics
  • Fig. 42 France intravenous solutions market, 2018 - 2030 (USD Million)
  • Fig. 43 Key country dynamics
  • Fig. 44 Italy intravenous solutions market, 2018 - 2030 (USD Million)
  • Fig. 45 Key country dynamics
  • Fig. 46 Spain intravenous solutions market, 2018 - 2030 (USD Million)
  • Fig. 47 Key country dynamics
  • Fig. 48 Denmark intravenous solutions market, 2018 - 2030 (USD Million)
  • Fig. 49 Key country dynamics
  • Fig. 50 Sweden intravenous solutions market, 2018 - 2030 (USD Million)
  • Fig. 51 Key country dynamics
  • Fig. 52 Norway intravenous solutions market, 2018 - 2030 (USD Million)
  • Fig. 53 Asia Pacific intravenous solutions market, 2018 - 2030 (USD Million)
  • Fig. 54 Key country dynamics
  • Fig. 55 Japan intravenous solutions market, 2018 - 2030 (USD Million)
  • Fig. 56 Key country dynamics
  • Fig. 57 China intravenous solutions market, 2018 - 2030 (USD Million)
  • Fig. 58 Key country dynamics
  • Fig. 59 India intravenous solutions market, 2018 - 2030 (USD Million)
  • Fig. 60 Key country dynamics
  • Fig. 61 Australia intravenous solutions market, 2018 - 2030 (USD Million)
  • Fig. 62 Key country dynamics
  • Fig. 63 South Korea intravenous solutions market, 2018 - 2030 (USD Million)
  • Fig. 64 Key country dynamics
  • Fig. 65 Thailand intravenous solutions market, 2018 - 2030 (USD Million)
  • Fig. 66 Latin America intravenous solutions market, 2018 - 2030 (USD Million)
  • Fig. 67 Key country dynamics
  • Fig. 68 Mexico intravenous solutions market, 2018 - 2030 (USD Million)
  • Fig. 69 Key country dynamics
  • Fig. 70 Brazil intravenous solutions market, 2018 - 2030 (USD Million)
  • Fig. 71 Key country dynamics
  • Fig. 72 Argentina intravenous solutions market, 2018 - 2030 (USD Million)
  • Fig. 73 MEA intravenous solutions market, 2018 - 2030 (USD Million)
  • Fig. 74 Key country dynamics
  • Fig. 75 South Africa intravenous solutions market, 2018 - 2030 (USD Million)
  • Fig. 76 Key country dynamics
  • Fig. 77 Saudi Arabia intravenous solutions market, 2018 - 2030 (USD Million)
  • Fig. 78 Key country dynamics
  • Fig. 79 UAE intravenous solutions market, 2018 - 2030 (USD Million)
  • Fig. 80 Key country dynamics
  • Fig. 81 Kuwait intravenous solutions market, 2018 - 2030 (USD Million)
  • Fig. 82 Key company categorization
  • Fig. 83 Heat map analysis
  • Fig. 84 Company market share analysis, 2023
  • Fig. 85 Strategy mapping